|
WO2020053795A2
|
|
Process for the preparation of acalabrutinib and its intermediates
|
|
WO2020003272A1
|
|
An improved process for the preparation of venetoclax
|
|
AU2018354972A1
|
|
An improved process for the preparation of ribociclib and its salts
|
|
WO2019043587A2
|
|
A process for the preparation of treosulfan
|
|
CN111093626A
|
|
Stable liquid composition of pemetrexed
|
|
EP3649116A1
|
|
A process for preparing alectinib or a pharmaceutically acceptable salt thereof
|
|
WO2018158697A1
|
|
A process for the preparation of ixazomib citrate
|
|
CN110312727A
|
|
A kind of improved method for preparing borate
|
|
CN109689635A
|
|
A method of for purifying Carfilzomib intermediate
|
|
EP3490973A1
|
|
Polymorphic forms of belinostat and processes for preparation thereof
|
|
KR20180043360A
|
|
Process for preparing xylene-linked cyclic compounds
|
|
AU2016310632A1
|
|
Pharmaceutical compositions comprising Afatinib
|
|
US2018312494A1
|
|
Polymorphic forms of Afatinib free base and Afatinib dimaleate
|
|
WO2016170489A1
|
|
Pharmaceutical compositions of proteasome inhibitor
|
|
WO2016088031A1
|
|
A process for purification of carfilzomib
|
|
CN104768532A
|
|
Stable pharmaceutical composition of 5-AZA-2'peoxyotipine
|
|
WO2014020553A1
|
|
Salts of pralatrexate
|
|
WO2014016740A2
|
|
Improved process for the preparation of pralatrexate
|
|
WO2014020467A2
|
|
Process for the preparation of pyrazole substituted aminoheteroaryl compounds
|
|
EP2854768A1
|
|
Pharmaceutical compositions of pemetrexed
|
